These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 21901248)
1. Fibulin-3 promoter methylation alters the invasive behavior of non-small cell lung cancer cell lines via MMP-7 and MMP-2 regulation. Kim EJ; Lee SY; Woo MK; Choi SI; Kim TR; Kim MJ; Kim KC; Cho EW; Kim IG Int J Oncol; 2012 Feb; 40(2):402-8. PubMed ID: 21901248 [TBL] [Abstract][Full Text] [Related]
2. Fibulin-5 suppresses lung cancer invasion by inhibiting matrix metalloproteinase-7 expression. Yue W; Sun Q; Landreneau R; Wu C; Siegfried JM; Yu J; Zhang L Cancer Res; 2009 Aug; 69(15):6339-46. PubMed ID: 19584278 [TBL] [Abstract][Full Text] [Related]
3. Fibulin-3 suppresses Wnt/β-catenin signaling and lung cancer invasion. Chen X; Meng J; Yue W; Yu J; Yang J; Yao Z; Zhang L Carcinogenesis; 2014 Aug; 35(8):1707-16. PubMed ID: 24480807 [TBL] [Abstract][Full Text] [Related]
4. Role of fibulin-3 in lung cancer: in vivo and in vitro analyses. Xu S; Yang Y; Sun YB; Wang HY; Sun CB; Zhang X Oncol Rep; 2014 Jan; 31(1):79-86. PubMed ID: 24142183 [TBL] [Abstract][Full Text] [Related]
5. Fibulin-5 inhibits Wnt/β-catenin signaling in lung cancer. Chen X; Song X; Yue W; Chen D; Yu J; Yao Z; Zhang L Oncotarget; 2015 Jun; 6(17):15022-34. PubMed ID: 25909283 [TBL] [Abstract][Full Text] [Related]
6. CTHRC1 induces non-small cell lung cancer (NSCLC) invasion through upregulating MMP-7/MMP-9. He W; Zhang H; Wang Y; Zhou Y; Luo Y; Cui Y; Jiang N; Jiang W; Wang H; Xu D; Li S; Wang Z; Chen Y; Sun Y; Zhang Y; Tseng HR; Zou X; Wang L; Ke Z BMC Cancer; 2018 Apr; 18(1):400. PubMed ID: 29631554 [TBL] [Abstract][Full Text] [Related]
7. [EFEMP1 suppresses growth and invasion of lung cancer cells by downregulating matrix metalloproteinase-7 expression]. Lang Y; Meng J; Song X; Chen X Zhongguo Fei Ai Za Zhi; 2015 Feb; 18(2):92-7. PubMed ID: 25676403 [TBL] [Abstract][Full Text] [Related]
8. Derlin-1 is overexpressed in non-small cell lung cancer and promotes cancer cell invasion via EGFR-ERK-mediated up-regulation of MMP-2 and MMP-9. Dong QZ; Wang Y; Tang ZP; Fu L; Li QC; Wang ED; Wang EH Am J Pathol; 2013 Mar; 182(3):954-64. PubMed ID: 23306155 [TBL] [Abstract][Full Text] [Related]
9. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression. Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879 [TBL] [Abstract][Full Text] [Related]
10. siRNA-TMEM98 inhibits the invasion and migration of lung cancer cells. Mao M; Chen J; Li X; Wu Z Int J Clin Exp Pathol; 2015; 8(12):15661-9. PubMed ID: 26884835 [TBL] [Abstract][Full Text] [Related]
11. IDH1 mutation promotes lung cancer cell proliferation through methylation of Fibulin-5. Yan B; Hu Y; Ma T; Wang Y Open Biol; 2018 Oct; 8(10):. PubMed ID: 30305430 [TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA SNHG15 indicates poor prognosis of non-small cell lung cancer and promotes cell proliferation and invasion. Dong YZ; Meng XM; Li GS Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2671-2679. PubMed ID: 29771418 [TBL] [Abstract][Full Text] [Related]
13. Tumor-associated macrophages provide a suitable microenvironment for non-small lung cancer invasion and progression. Wang R; Zhang J; Chen S; Lu M; Luo X; Yao S; Liu S; Qin Y; Chen H Lung Cancer; 2011 Nov; 74(2):188-96. PubMed ID: 21601305 [TBL] [Abstract][Full Text] [Related]
14. Salinomycin suppresses TGF-β1-induced EMT by down-regulating MMP-2 and MMP-9 via the AMPK/SIRT1 pathway in non-small cell lung cancer. Hwang KE; Kim HJ; Song IS; Park C; Jung JW; Park DS; Oh SH; Kim YS; Kim HR Int J Med Sci; 2021; 18(3):715-726. PubMed ID: 33437206 [TBL] [Abstract][Full Text] [Related]
15. Methylation-mediated loss of SFRP2 enhances invasiveness of non-small cell lung cancer cells. Zhang X; Rong X; Chen Y; Su L Hum Exp Toxicol; 2018 Feb; 37(2):155-162. PubMed ID: 29320940 [TBL] [Abstract][Full Text] [Related]
16. High-mobility group box 1-mediated matrix metalloproteinase-9 expression in non-small cell lung cancer contributes to tumor cell invasiveness. Liu PL; Tsai JR; Hwang JJ; Chou SH; Cheng YJ; Lin FY; Chen YL; Hung CY; Chen WC; Chen YH; Chong IW Am J Respir Cell Mol Biol; 2010 Nov; 43(5):530-8. PubMed ID: 19933377 [TBL] [Abstract][Full Text] [Related]
17. Frequent inactivation of RAMP2, EFEMP1 and Dutt1 in lung cancer by promoter hypermethylation. Yue W; Dacic S; Sun Q; Landreneau R; Guo M; Zhou W; Siegfried JM; Yu J; Zhang L Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4336-44. PubMed ID: 17671114 [TBL] [Abstract][Full Text] [Related]
18. LATS2 as a poor prognostic marker regulates non-small cell lung cancer invasion by modulating MMPs expression. Wu A; Li J; Wu K; Mo Y; Luo Y; Ye H; Mai Z; Guo K; Wang Y; Li S; Chen H; Luo W; Yang Z Biomed Pharmacother; 2016 Aug; 82():290-7. PubMed ID: 27470365 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of ZNF746 suppresses invasion and epithelial to mesenchymal transition in H460 non-small cell lung cancer cells. Kim B; Sohn EJ; Jung JH; Shin EA; You OH; Im J; Kim SH Oncol Rep; 2014 Jan; 31(1):73-8. PubMed ID: 24145959 [TBL] [Abstract][Full Text] [Related]
20. Osthole inhibits the invasive ability of human lung adenocarcinoma cells via suppression of NF-κB-mediated matrix metalloproteinase-9 expression. Kao SJ; Su JL; Chen CK; Yu MC; Bai KJ; Chang JH; Bien MY; Yang SF; Chien MH Toxicol Appl Pharmacol; 2012 May; 261(1):105-15. PubMed ID: 22503731 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]